EUVIMEDEUVIMED entdecken
Open Access

Atypical neurofibromas reveal distinct epigenetic features with proximity to benign peripheral nerve sheath tumor entities

Catena Kresbach iD, Matthias Dottermusch iD, Alicia Eckhardt, Inka Ristow iD, Petros Paplomatas, Lea Altendorf, Annika K Wefers iD, Michael Bockmayr iD, Sarra Belakhoua, Ivy Tran, Lara Pohl, Sina Neyazi iD und 9 weitere

Neuro-Oncology · 2023

DOI: 10.1093/neuonc/noad053 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuro-Oncology, 2023. Verfasst von Catena Kresbach und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostics, Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Germany. Hauptthemen laut MEDLINE: Neurofibromatosis 1, Neurofibrosarcoma, Neurofibroma, Nerve Sheath Neoplasms. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Mildred Scheel Cancer Career Center, Fördergemeinschaft Kinderkrebszentrum Hamburg, Friedberg Charitable Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Plexiform neurofibromas can transform into atypical neurofibromas (ANF) and then further progress to aggressive malignant peripheral nerve sheath tumors (MPNST). ANF have been described to harbor distinct histological features and frequent loss of CDKN2A/B. However, histological evaluation may be rater-dependent, and detailed knowledge about the molecular mechanisms of malignant transformation is scarce. In general, malignant transformation can be accompanied by significant epigenetic changes, and global DNA methylation profiling is able to differentiate relevant tumor subgroups. Therefore, epigenetic profiling might provide a valuable tool to distinguish and characterize ANF with differing extent of histopathological atypia from neurofibromas and MPNST.

Methods

We investigated 40 tumors histologically diagnosed as ANF and compared their global methylation profile to other peripheral nerve sheath tumors.

Results

Unsupervised class discovery and t-SNE analysis indicated that 36/40 ANF cluster with benign peripheral nerve sheath tumors with clear separation from MPNST. 21 ANF formed a molecularly distinct cluster in proximity to schwannomas. Tumors in this cluster had a frequent heterozygous or homozygous loss of CDKN2A/B and significantly more lymphocyte infiltration than MPNST, schwannomas, and NF. Few ANF clustered closely with neurofibromas, schwannomas, or MPNST, raising the question, whether diagnosis based on histological features alone might pose a risk to both over- and underestimate the aggressiveness of these lesions.

Conclusions

Our data suggest that ANF with varying histological morphology show distinct epigenetic similarities and cluster in proximity to benign peripheral nerve sheath tumor entities. Future investigations should pay special respect to correlating this methylation pattern to clinical outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neurofibromatosis 1NeurofibrosarcomaNeurofibromaNerve Sheath NeoplasmsNeurofibromatosesNeurilemmomaHumansEpigenesis, Genetic

Stichwörter der Autor:innen

DNA methylationatypical neurofibromaclassificationdiagnostic markerperipheral nerve sheath tumors

Autor:innen und Institutionen

  • Department of Diagnostics, Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Germany.
  • Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Research Institute Children's Cancer Center, Hamburg, Germany.
  • Mildred Scheel Cancer Career Center HaTriCS4, University Medical Center Hamburg- Eppendorf, Hamburg, Germany.
  • Lab of Radiobiology & Experimental Radiation Oncology, Hubertus Wald Tumorzentrum, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Department of Diagnostic and Interventional Radiology and Nuclear Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

ORCID-Profile: Catena Kresbach, Matthias Dottermusch, Inka Ristow, Annika K Wefers, Michael Bockmayr, Sina Neyazi, Said Farschtschi, Lennart Well, Reinhard E Friedrich, David Reuss, Matija Snuderl, Christian Hagel, Victor-Felix Mautner, Ulrich Schüller

Förderung

  • Mildred Scheel Cancer Career Center
  • Fördergemeinschaft Kinderkrebszentrum Hamburg
  • Friedberg Charitable Foundation
  • Nothing is Forever

Zitieren

APA

Kresbach, C., Dottermusch, M., Eckhardt, A., Ristow, I., Paplomatas, P., Altendorf, L., Wefers, A. K., Bockmayr, M., Belakhoua, S., Tran, I., Pohl, L., Neyazi, S., Bode, H., Farschtschi, S., Well, L., Friedrich, R. E., Reuss, D., Snuderl, M., Hagel, C., …, & Schüller, U. (2023). Atypical neurofibromas reveal distinct epigenetic features with proximity to benign peripheral nerve sheath tumor entities. Neuro-Oncology. https://doi.org/10.1093/neuonc/noad053

Vancouver

Kresbach C, Dottermusch M, Eckhardt A, Ristow I, Paplomatas P, Altendorf L, et al. Atypical neurofibromas reveal distinct epigenetic features with proximity to benign peripheral nerve sheath tumor entities. Neuro-Oncology. 2023. doi:10.1093/neuonc/noad053

BibTeX
@article{Kresbach2023,
  author = {Kresbach, Catena and Dottermusch, Matthias and Eckhardt, Alicia and Ristow, Inka and Paplomatas, Petros and Altendorf, Lea and Wefers, Annika K and Bockmayr, Michael and Belakhoua, Sarra and Tran, Ivy and Pohl, Lara and Neyazi, Sina and Bode, Helena and Farschtschi, Said and Well, Lennart and Friedrich, Reinhard E and Reuss, David and Snuderl, Matija and Hagel, Christian and Mautner, Victor-Felix and Schüller, Ulrich},
  title = {Atypical neurofibromas reveal distinct epigenetic features with proximity to benign peripheral nerve sheath tumor entities},
  journal = {Neuro-Oncology},
  year = {2023},
  doi = {10.1093/neuonc/noad053}
}
Kostenlos starten →